Notice of Change to participation on PAR-18-514 " Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer?s Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)"

Notice Number: NOT-OD-18-125

Key Dates
Release Date: February 21, 2018

Related Announcements
PAR-18-514

Issued by
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Purpose

The purpose of this Notice is to inform potential applicants that ORIP/OD is not participating in PAR-18-514, "Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)". This is effective as of the Release Date of this Notice.
The following portions of the FOA are edited to reflect this change.

Currently reads:
Components of Participating Organizations
 
National Institute on Aging (NIA)
 
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers.  The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
 
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)  

Revised to read:
Components of Participating Organizations
 
National Institute on Aging (NIA)

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

All FOA inquiries should be directed to NIA contacts listed in the PAR-18-514.